Follow
It is currently Sat Oct 21, 2017 6:51 am
Change font size

  • Advertisement

*New MMAR Regulations*

by papapuff » Mon Sep 11, 2017 3:10 pm

Whitecourt Star



Marijuana facility proposed in Fort Assiniboine

By Peter Shokeir
Monday, September 11, 2017

Fort Assiniboine may soon be home to an industrial greenhouse that will grow and sell medical marijuana while creating jobs.

Darrel Renkema, co-founder and president of Quadel Growers, gave a presentation on this proposed facility to Woodlands County council at its regular meeting on Sept. 5.

“The feelings of people who are already operating these is that they’re are not a danger to the community,” said Woodlands County Mayor Jim Rennie. “These facilities are very secure. The government is mandating what kind of security they have to have.”

Rennie added that traffic would be very minimal—with only employees and two delivery trucks per day—and that odours would be non-existent thanks to filters.

“Nothing is released into the atmosphere,” he said.

Renkema emphasized how secure the new facility would be. Employees will require background checks and the facility will be under 24-hour security.

“There won’t be any location other than the bathrooms that doesn’t have cameras in it,” he said.

As a long-time resident of Fort Assiniboine, Renkema said he was proud to bring his business there.

“Most people, they say it’s a good place to grow up but not really great to go back to and I never felt that. I always liked going back there,” he said.

Renkema also outlined the benefits of medical marijuana, saying how it can help people with epilepsy, multiple sclerosis and Parkinson’s disease.

“That’s divine in my opinion,” he said. “There are people out there who don’t realize what medical marijuana can do for some people.”

Coun. Dale Kluin said he supported this proposed facility and appreciated how many jobs it would bring to the community. The facility would initially employ between 35 to 40 people and eventually grow to 100, Renkema said, adding that he would seek local help before looking outwards.

“We need something in Fort Assiniboine right now,” Kluin said. “These guys are getting on the stream at the right time. Timing is everything.”

Kluin said he was also excited over how the product would be shipped via Canada Post.

“With a business like this, I don’t know how we’re going to lose our post office in town,” he said.

The only concern that both Kluin and Rennie had regarding the facility was how it should be taxed. Rennie pointed out how agriculture pays too little taxes in Fort Assiniboine, with a $100 million facility only having to pay $10,000 for a year. Kluin added that this marijuana wouldn’t be a typical crop.

“To me it’s going to be different because it’s on the medical side,” Kluin said.

Council accepted the presentation as information. The Woodlands County Municipal Planning Commission will decide whether or not the facility gets approved on Sept. 20.
papapuff
 
Posts: 10921
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

Advertisement


Visit the Hempology 101 store today!

by papapuff » Tue Sep 12, 2017 12:40 pm

The Barrie Examiner



City will sell Skytek land for plant


Tuesday, September 12, 2017

The sale of city-owned land for a medical marijuana facility in south-Barrie has been pushed back to Jan. 31, 2018.

Councillors gave initial approval to the closing date extension Monday, with no discussion.

Skytek Pharmaceutical wants to buy 36-48 Rawson Dr. to build a $7-million, 65,000 square foot plant to employ 120 people, with a potential for 330 more jobs.

The company would pay $647,250 for nearly 5.2 acres of land.

This deal initially came to Barrie councillors in June, 2015, with a tentative closing date that August.

But after council approved the sale, the federal government announced changes to the laws regulating the licensing of medical marijuana growing facilities.

So licence applications were put on hold.

Skytek has applied for licensing with Health Canada and is in the process, confident it will get done this year.

Skytek would grow and process medical marijuana. Orders would be filled by mail and couriered throughout Canada for patients with prescriptions. All shipments would be done indoors. There would be no retail sales permitted.

The facility would use state-of-the-art filters to eliminate odours and recycle water used for irrigation, so there would not be any discharge into the city's sewer system from the marijuana production.

There would be electronic security access, a fenced facility and an electrical entry gate.

Development charges for the facility would be $1.3 million.

In 2015, city council approved an expansion of permitted uses within the industrial section of Barrie's comprehensive zoning bylaw which included medical marijuana production facilities.

Licenced producers must comply with municipal zoning bylaws and notify local authorities of their intentions, including site location. These producers can be licensed to grow, process, sell , ship, deliver, transport, destroy, export or import marijuana for medical purposes.

The medical benefits of marijuana remain controversial, although the relief of chronic pain is most often cited.

Health Canada says dried marijuana is not an approved drug or medicine in this country. The Canadian government doesn't endorse the use of marijuana, but the courts have required reasonable access to a legal source of marijuana when authorized by a physician.
papapuff
 
Posts: 10921
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Wed Sep 13, 2017 10:38 am

The Province



Maple Ridge greenhouse heralds age of green cannabis production

DERRICK PENNER
(Vancouver Sun)

Published: September 12, 2017
Updated: September 13, 2017 6:00 AM
Filed Under:The Province > News > Local News

Maple Ridge greenhouse heralds cutting edge of cannabis production at cusp of legalization
The slender green shoots of Tantalus Labs’ first medical marijuana crop are just beginning to sprout to a recognizable form in the bright, airy confines of the company’s Maple Ridge greenhouse at a fortuitous time.

Vancouver-headquartered Tantalus is set to become the first industrial-scale cannabis greenhouse at the same time all of Canada is expecting a multi-billion-dollar market for legal, recreational weed to open up by next Canada Day.

And the company’s spic-and-span, state-of-the-art greenhouse at the bottom of a sun-drenched slope in the Fraser Valley opens up an interesting discussion about how to supply a potentially booming trade.

Tantalus received its Health Canada licence at the end of May, and is banking on earning green credibility for environmentally sustainable crops.

“For Tantalus Labs, that sustainable option is a core differentiator for us,” said Dan Sutton, co-founder and managing director of the five-year-old firm.


The greenhouse facility is a technologically controlled environment in which everything from the temperature and humidity to water flow, nutrient consumption and soil pH — 30 parameters in all — are measured and controlled to avoid the use of pesticides and other chemicals.

A slogan that is stencilled onto a wide roll-up door inside the main greenhouse reads: “Futureweed.”

“For us, we’re trying to demonstrate that greenhouses can cultivate excellent quality, consistently pesticide-free, consistently quality assured, mould free, chemical-free, heavy-metal free cannabis,” Sutton said, “and that we can do it repeatedly over time.”

Tantalus has spent “millions” building the 50,000-square-foot greenhouse and 25,000-square-foot production building, with plans to build a second 50,000-square-foot greenhouse on other land that the company owns.

“I think that it’s an economic inevitability that the majority, the gross majority, of cannabis in a competitive marketplace for recreational or medicinal cannabis will be cultivated in greenhouses,” Sutton said. “The economics are just too staggering.”

Sutton refers to its product as “sun-grown,” and plans to use 90 per cent less electricity than a typical indoor growing operation under lights and produce cannabis at one-third to one-quarter the cost.

Tantalus was incorporated in 2012 before Colorado and Washington state legalized marijuana and supplying a recreational market in Canada wasn’t even on the firm’s horizon, said Sutton, who started his business career in clean energy.

“I saw it as an opportunity to write a textbook,” Sutton said.

Prime Minister Justin Trudeau’s push to legalize recreational pot coincides with Tantalus’ plans to begin commercial medicinal sales sometime next summer.

Canada’s market for recreational cannabis could be worth $13 billion to $23 billion per year with demand for product swelling to as much as 600,000 kilograms in just a few years, even under a “low-end estimate,” according to a 2016 study by the accounting firm Deloitte.

In 2016, on the legal side of medical marijuana, some 40 producers grew about 31,000 kilograms of cannabis, according to a report from PI Financial analyst Jason Zandberg.

Federal legislation calls for a division of responsibilities between the feds and provinces to enact legalization, with the federal government responsible for registering, licensing and regulating producers for the recreational market, similar to the regime for medical producers.

That licensing regime has sparked criticism from marijuana activists who contend that it favours the bigger, already-established producers, which will shut out grassroots producers who have long produced marijuana illegally, in defiance of prohibition.

However, even advisers to the federal government’s legalization initiative contemplated allowing formerly illegal, underground growers to come out of the shadows and offer their expertise to the market.

“We talk about artisanal and craft producers — we want a diversity of producers,” said Anne McLellan, a lawyer, former federal cabinet minister and chairwoman of the Task Force on Cannabis Legalization and Regulation.

“There’s an awful lot of expertise that’s outside the legal system right now and you wouldn’t want to lose all that,” McLellan said in an interview earlier this year.

And to generate enough cannabis to cut into the unregulated black market, Sutton said, will require a lot of producers.

“I think there are a host of excellent cannabis producers from diverse regions across the province,” Sutton said, “and effective regulation will endorse the most sophisticated of those producers.”

And the best growers won’t just be the ones that produce top quality cannabis, but those that can also meet the needs of a regulatory system when it comes to quality assurance, security and transparency, Sutton said.

Tantalus isn’t the only medicinal grower to latch onto a greenhouse model for production either.

In June, Vancouver-headquartered medicinal producer Emerald Health Therapeutics announced it had struck a $20 million joint venture with B.C.-based greenhouse giant Village Farms that would instantly dwarf Tantalus.

Village Farms committed an initial 1.1 million square feet — some 10 hectares — of greenhouse space to cannabis production, subject to the venture obtaining a licence under the existing medicinal licensing regime, and potentially under the recreational regime.

depenner@postmedia.com

twitter.com/derrickpenner
papapuff
 
Posts: 10921
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Wed Sep 13, 2017 12:42 pm

Ottawa Business Journal



Ottawa-area pot producer Canopy Growth to supply medicinal cannabis in Australia

BY:
OBJ staff

PUBLISHED:
Sep 13, 2017 2:54pm EDT

Two days after announcing an agreement to extend its reach into Europe, Smiths Falls-based Canopy Growth Corp. says it has inked a deal to bolster its presence Down Under.

Canada’s largest licensed cannabis producer said Wednesday it will be the exclusive supplier of medical cannabis in the Australian market for AusCann Group Holdings. As part of the deal, Canopy said it will transfer “a range of medicines” to the AusCann for research and sale in Australia.

Canopy Growth (TSX:WEED) already owns a minority stake in the Perth-based company, and Canopy CEO Bruce Linton is a member of the firm’s board of directors. AusCann received its licence to grow medical pot in May and announced it would import cannabis from Chile in partnership with Canopy Growth until its own growing facility was operational.

In a statement, Canopy Growth said the Australian market, which experts estimate to be worth $100 million per year, “continues to present attractive growth opportunities for medical cannabis.” The company said the agreement allows it continue to pursue other opportunities in Australia.

It’s the second international agreement for Canopy Growth this week. On Monday, the firm announced it had signed a supply license agreement with Spanish pharmaceutical producer Alcaliber.

Mr. Linton has made no secret of his desire to take Canopy Growth global.

“We want to be really not very Canadian. We want to dominate the world,” he said in a speech to local business leaders last year.

Canopy Growth shares were down 0.7 per cent to $10.01 in midafternoon trading on the Toronto Stock Exchange Wednesday.
papapuff
 
Posts: 10921
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Wed Sep 13, 2017 12:49 pm

Welland Tribune



Control over medical marijuana grow-ops needed

By The Tribune
Wednesday, September 13, 2017

Wainfleet planning staff will consult with the township’s lawyer before a report comes back on a possible municipal licensing policy to deal with proposed medical marijuana grow-ops, council heard Tuesday night.

Township planner Sarah Ivins said the township doesn’t have a municipal licensing policy and staff had questions as to whether it could implement one to deal with a medical marijuana facility or that specific type of use.

“We want to make sure we cover all of our bases before we propose options for council … there’s a lot to consider before a staff report,” she said, adding one may be ready by the first week of October when council meets next.

Discussion about a municipal licensing policy or bylaws around medical marijuana facilities came about after a presentation by resident Graeme Ross on a marijuana grow-op at the east end of Wilford Road.

“I am here on behalf of the residents of east Wilford Road as a follow up to our presentation at the last council meeting. In just nine short days from our appeal for help at last council meeting, the proposed medical marijuana grow-op located at 61770 Wilford Rd., the former Railway Gardens Greenhouses, had a warrant served …,” said Ross.

He said Niagara Regional Police raided the facility and located and seized 668 marijuana plants with an estimated street value of $668,000. Two men were arrested and charged by police.

“There were no Health Canada licenses in place. We are here tonight to reiterate our need for help. Just because there has been a successful warrant served and arrests made, we still need swift action on the part of council to get the setback bylaw enforced for this particular property and new municipal licensing and bylaw policies in place.”

Ross said if a municipal licensing policy were already in place the issue residents with this facility re-establishing its production would not exist. He said a new municipal licensing should include zero tolerance for offences and non-compliance.

“This seizure and arrests are a definite step in the right direction regarding this facility, keeping in mind an arrest does not mean a conviction. But we cannot view this warrant as an end to the issues with this facility …”

He said once a licence is issued it will be even harder for council and authorities to have access to the facility to assess what is happening inside.

“Not to mention once again putting our neighborhood at risk. Our fight to keep this facility and others like it out of our township is far from over and once again the time for action is now.

“I put it to council that if this were to occur across the street from your home, I suspect you would take the same kind of interest and have the same passion in this as we do. You were elected by us … and every street and road in Wainfleet is your street and road,” he said at the end of his presentation.

While council had no questions for Ross, Ald. Richard Dykstra asked Ivins about bylaws and licensing in place in other municipalities.

Ivins said Wainfleet residents gave her a copy of a Mississauga bylaw and that police told her it was one of the best bylaws that had seen in terms of regulating the facilities.

In response to a question from Mayor April Jeffs, the planner said the township does have a setback bylaw, which hasn’t been enforced and site specific zoning bylaws as well.

She said township’s lawyer was being consulted before any enforcement took place.

“If we press charges … we want to follow the right process.”

Ald. Ted Hessels suggested sending the owners of the Wilford Road property a copy of the setback bylaw so they would be aware of it.

“That would be proactive I think,” said Hessels.

Ivins said that was being looked into as well.
papapuff
 
Posts: 10921
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Wed Sep 13, 2017 2:44 pm

The News



Stellarton remains optimistic Vida Cannabis will get marijuana production OK

Published on September 13, 2017

It’s been more than two years and the former Clairtone building in Stellarton is still empty.

The long-awaited 300 medicinal marijuana jobs haven’t yet materialized. There’s no pot being grown inside the 315,000-square-foot, fully renovated building’s walls.

Health Canada, which has the authority to issue medicinal marijuana licences to companies in this country, is refusing to acknowledge whether Vida Cannabis, the owner of that building in Stellarton, has even applied for such a licence. The company has repeatedly claimed it has applied. But, so far, Health Canada’s website still shows the company has not received that stamp of approval from the federal government.

And yet – despite this lack of activity at the site and the company’s silence – the mood in Stellarton is still one of hope.

Community leaders are clinging to the hope of a bonanza of good-paying, long-term jobs and the boost to the economy these jobs would provide. Many people have gone so far as to buy shares in Vida Cannabis.

Mayor Danny MacGillivray, who does not have any ownership stake in the company, points to Vida Cannabis’s payment of its back taxes on the property about a year ago as a sign the company is still serious about moving ahead with its marijuana operation.

“They were in arrears but they paid them up and now they’re up to date,” said the mayor in an interview Wednesday. “It made us think they must be going to do something with this.”

In the community of 4,200 souls, the rumour mill has been working overtime. Those rumours have pegged the amount of money the company has invested in the property, for which it initially paid $500,000, at up to $15 million.

But nobody except the execs at Vida Cannabis and perhaps its shareholders know the real amount of that investment.

Certainly, Vida Cannabis has put a lot of work into Peter Munk’s circa-1960s Clairtone Sound Corporation stereo and television plant after buying the empty shell two years ago.

“They put a lot of money into it. It was a dilapidated old building and they put a new roof on it and everything. They re-did the whole outside. It’s like a whole new building,” said Mayor MacGillivray.

“We’re optimistic that something will happen,” he said.

Cathy Covey, the broker and owner of Sunrise Brokerage & Sales in Stellarton, was the realtor who stickhandled that real estate deal back in 2014. In an interview, she said Vida Cannabis paid fair market value for the property, the full amount of the asking price established by the seller, the Town of Stellarton.

She’s convinced Vida Cannabis still intends to go ahead with plans for a medicinal marijuana operation on the site and quickly dismissed any notion that the company might have simply bought the old Clairtone property as a land deal, speculating on future capital gains in the value of the land.

“It’s a business deal,” said Covey. “They’ve rebuilt the building. It was renovated specifically for growing marijuana.”

The Sunrise Brokerage owner is also a shareholder in Vida Cannabis and so privy to corporate information provided during the company’s annual general meetings. In the interview, she would not share that information, saying it was confidential. But Covey did say that when the company does launch its medicinal marijuana operations, people will sit up and take notice.

“It’ll be big news when it happens,” she said.

Mayor MacGillivray’s biggest worry about the Vida Cannabis plant isn’t whether it will ever open but its capacity to meet a growing demand for pot.

“There’s a big demand for the product and the government won’t be able to fill all the orders,” he said. “Recreational marijuana is supposed to become legal in July. In Las Vegas, when they legalized it, they ran out.”
papapuff
 
Posts: 10921
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Fri Sep 15, 2017 3:32 pm

SmallCapPower (press release)



Canopy Growth Corporation (TSE:WEED) inks supply agreement for Australia, New Brunswick, and sells subsidiary

SmallCapPower | September 15, 2017: Canopy Growth Corporation (TSX: WEED) has had an eventful past week. The marijuana market leader in Canada announced today that it had signed a Memorandum of Understanding (MOU) to supply cannabis products to the province of New Brunswick for two years with an estimated retail value of $40 million in its first year.

On Thursday, Canopy Growth said it has sold its wholly-owned subsidiary Mettrum (Bennett North) to Cannabis Care Canada (CCC). Mettrum is licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to produce and sell dried cannabis and cannabis oil.

CCC is financially backed by Laborers International Union of North America (“LiUNA”), North America’s single largest construction union with over 100,000 Canadian members. Under the terms of the agreement, CCC has paid $7.0 million in cash to acquire Bennett Road North and entered into a three-year “take or pay” Supply Agreement with Canopy Growth for high-quality dried flowers and refined cannabis resin, with the sale of product at Canopy Growth’s discretion.

Chairman & CEO of Canopy Growth Bruce Linton said, “Entering into an agreement of this scale with Cannabis Care Canada signals loud and clear that attitudes towards cannabis are transforming across mainstream society as workers and employers increasingly recognize the merits of medical cannabis over other existing alternatives.”

And, on Wednesday, Canopy Growth reported that it has entered into a supply agreement with AusCann Group Holdings Ltd., whereby Canopy Growth will act as AusCann’s exclusive supplier of medical cannabis for the Australian market, beginning with the transfer of a range of medicines for research and commercialization in Australia.

Shares of Canopy Growth have powered more than 50% higher from its early June 2017 lows to its current price of $10.27.

Canopy Growth Corporation stock trades at TTM price to sales value of 35.26x and price to book of 2.60x.
papapuff
 
Posts: 10921
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Mon Sep 18, 2017 10:31 am

The News Reports



Emerald Health Therapeutics Launches Island Mist, One of Canada’s Highest CBD and CBD to THC Ratio Dried Flower Products

September 18, 2017 By Staff Writer

Emerald Health Therapeutics Launches Island Mist, One of Canada’s Highest CBD and CBD to THC Ratio Dried Flower Products

VICTORIA, British Columbia, Sept. 18, 2017 (GLOBE NEWSWIRE) — Emerald Health Therapeutics Inc. (Therapeutics) (TSX-V:EMH) (OCTQX:EMHTF) has released Island Mist, its proprietary high cannabidiol (CBD) and high CBD to THC ratio dried flower product. This Indica-dominant strain, which came out of Emerald’s broad seed bank through extensive screening and characterization, contains 15.9% CBD and just 0.4% […]

VICTORIA, British Columbia, Sept. 18, 2017 (GLOBE NEWSWIRE) — Emerald Health Therapeutics Inc. (Therapeutics) (TSX-V:EMH) (OCTQX:EMHTF) has released Island Mist, its proprietary high cannabidiol (CBD) and high CBD to THC ratio dried flower product. This Indica-dominant strain, which came out of Emerald’s broad seed bank through extensive screening and characterization, contains 15.9% CBD and just 0.4% THC, a ratio of 40:1. This product can be purchased by holders of a medical license registered with Emerald Health Botanicals (Botanicals), Therapeutics’ wholly owned subsidiary and a Licensed Producer under Access to Cannabis for Medical Purposes Regulations (ACMPR).

Botanicals currently sells a line of six dried flower products, including four strains with THC levels ranging from 16.3% to 21.5%; a high CBD strain; and a strain containing both THC and CBD.

Botanicals now offers eight oils with varying levels of THC, THCA, CBD, and THC to CBD ratios. This product line includes the company’s recently launched CBD-25 and CBD-50 medical cannabis oils containing approximately 25 milligrams and 50 mg of CBD per milliliter. Management believes CBD-50 contains the highest amount of CBD per milliliter on the ACMPR market today. CBD-50 provides a unique option to doctors and patients seeking high CBD potency with minimal THC.

“Island Mist offers patients who prefer dried flower with significant CBD and minute amounts of THC and thus little to no psychoactive effects,” said Dr. Bin Huang, President and CEO of Emerald. “We have built a balanced product line that we will add to with our continuing pursuit of distinct products to meet different needs and expectations in the ACMPR marketplace and the anticipated legal Canadian recreational market in 2018.”

Join us on our journey of making lives better through cannabis science.

About Emerald Health Therapeutics Inc.

Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF) operates primarily through Emerald Health Botanicals Inc. (“Botanicals”), a wholly owned subsidiary of the Company and a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations. Botanicals is authorized to produce and sell both dried medical cannabis flower and medical cannabis oil in Canada. Botanicals currently operates an indoor facility in Victoria, BC, and is progressing on expansion plans for a 32-acre property in Metro Vancouver and a joint venture with Village Farms utilizing a 25 acre existing greenhouse complex in Delta, BC. Botanicals is one of Canada’s most medically focused licensed producers, with a team highly experienced in life sciences product development and large-scale agribusiness. Its vision is to be a leading provider of cannabis products through its production capabilities, proprietary genetics, value-added products and branding, and superb customer experience. Emerald Health Therapeutics is part of the Emerald Health group, which comprises multiple companies advancing diverse botanical, nutraceutical and pharmaceutical products that may provide wellness and medical benefits by interacting with the body’s endocannabinoid system.

For investor and media contacts:

invest@emeraldhealth.ca

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.

We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to legalization of non-therapeutic cannabis sales in Canada; participation in the legalized non-therapeutic cannabis industry; growth in the extract-based market; increased production of cannabis; commercial operations; construction or conversion of production facilities; applications for licensing; obtaining such licenses; commencement of production of cannabis at the Company’s facilities; estimates of production capacity at such facilities; contributions of cash to the JV; international opportunities for the Company; commencement of clinical trials; the Company becoming a leading Canadian supplier of cannabis products; expected timing of any of the above matters; and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Emerald Health Therapeutics Inc. does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, failure of the federal government to approve legislation legalizing sales of non-therapeutic adult-use cannabis; failure to obtain Health Canada and other regulatory approvals; failure to obtain necessary financing; results of production and sale activities; the Company’s historical experience with medical marijuana operations; results of scientific research; uninsured risks; regulatory changes; difficulties in construction or in obtaining qualified contractors to complete construction or conversion of facilities; availability of production facilities; timeliness of government approvals and the granting of permits and licenses; changes in prices and costs; actual operating and financial performance of facilities; equipment and processes relative to specifications and expectations; as well as the other risk factors set out in the Company’s annual information form and other filing with the applicable Canadian securities regulators, which may be viewed at http://www.sedar.com. Actual results may differ materially from those expressed or implied by such forward-looking statements.

Source: Health Care
papapuff
 
Posts: 10921
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Tue Sep 19, 2017 10:13 am

Marketwired (press release)



September 19, 2017 03:00 ET

Hydropothecary announces kosher certification on processed medical marijuana products

GATINEAU, QC--(Marketwired - September 19, 2017) - The Hydropothecary Corporation ("THCX" or the "Company") (TSX VENTURE: THCX) is pleased to announce its processed medical marijuana products have been granted kosher certification by the Ottawa Vaad HaKashrut. It is the only kosher certification currently granted to cannabis products in Canada.
The kosher certification, includes Decarb, the ready-to-consume activated marijuana powder product line, Elixir cannabis peppermint oil and the H2 line of milled products.

"Kosher certification is important to Hydropothecary because it reflects our emphasis on rigorous testing, independent third-party oversight and our focus on easy-to-use product innovations. As the only medical marijuana company in Canada with current kosher-certified processed products, we take great pride in having the support of the Council for Kashrut," said Hydropothecary CEO and co-founder, Sebastien St-Louis.

The announcement of the certification, by Vaad HaKashrut director, Rabbi Levy Teitlebaum, comes just in time for Rosh Hashanah, on September 20.

"Kosher certification is something that is relied upon by many people, including vegans, vegetarians and people who are careful about what they consume, as a symbol of trust. What this certification shows is the value placed on proper etiquette for kosher and for being able to care for people. That is a beautiful harmony between the Council and Hydropothecary," Rabbi Teitlebaum said.

Obtaining kosher certification requires several components, including an audit of cleaning protocols, kosher compliance review and on-site inspections throughout the year.

"This is a rigorous, independent, third-party certification process that goes from A to Z. Hydropothecary's products not only qualify, but certification is gladly given because it's important for what's needed in this new sector," said Rabbi Teitlebaum.

About The Hydropothecary Corporation

The Hydropothecary Corporation is an authorized licensed producer and distributor of medical cannabis licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations (Canada). Hydropothecary provides sungrown and rigorously tested medical cannabis of uncompromising quality. Hydropothecary's branding, cannabis product offering, patient service standards and product pricing are consistent with THCX's positioning as a premium brand for a legal source for medical cannabis within this new marketplace. In addition to medical cannabis production and sales, Hydropothecary explores various research and development opportunities for cannabinoid extracts, drugs and combinatory chemistry. In addition, the company is investigating the development and patenting of novel technologies related to medical cannabis, as well as the import and export of medical cannabis.

FAQs About Kosher Certification and Medical Marijuana

Rabbi Levy Teitlebaum
Ottawa Vaad HaKashrut

What does kosher certification mean?

"Kosher certification is given to foods and consumed items that conform to kashrut or Jewish dietary law. This applies to processed foods, including plant products and animal products. Kosher ensures that what we are ingesting has been reviewed and conforms to dietary and religious needs."

How will those taking medical marijuana know a product is kosher certified?

"Our symbol will appear on the label of every Hydropothecary product that is kosher certified. Clients can also obtain a Letter of Kosher Certification from Hydropothecary."

Why is the advantage of kosher certification for medical marijuana products?

"As with the purchase of all consumable products, clients searching for kosher certification will know that their products adhere to the highest standards of kosher purity."

When legalization of marijuana comes into effect in July, 2018, how will that affect kosher certification?

"Medical products required for health and wellbeing are eligible for kosher certification. With legalization of marijuana for recreational use, however, we will have to consider the ethics of using a product simply for enjoyment."

Image Available: http://www.marketwire.com/library/MwGo/ ... 1ca019.jpg

CONTACT INFORMATION

Media Contact Information
Julie Beun
Publicity and Media Relations
613 371 9060
julie@thehydropothecary.com

Investor Relations Contact Information
Jennifer Smith
Manager of Financial Reporting and Investor Relations
1-866-438-THCX (8429)
invest@THCX.com
http://www.THCX.com
papapuff
 
Posts: 10921
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Tue Sep 19, 2017 10:28 am

Canada NewsWire (press release)




Aurora Begins Supplying German Medical Cannabis Market


NEWS PROVIDED BY
Aurora Cannabis Inc.

Export/Import Permits Received, First 50 kg Shipped

TSX: ACB

VANCOUVER, Sept. 19, 2017 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that it has received all the required permits to ship dried cannabis flower from Canada to Germany, enabling the Company to begin supplying the German medical cannabis market through its wholly-owned subsidiary Pedanios GmbH ("Pedanios").

Aurora is now in receipt of a Health Canada issued Export Permit, as well as provisional import status from the German Bundesopiumstelle (Federal Narcotics Bureau), to import medical cannabis products into Germany. On September 18, 2017, the Company shipped 50 kg of dried cannabis from its facility in Mountain View County, Alberta, to Berlin-based Pedanios, Germany's leading medical cannabis distributor. Import permits for additional product have been secured, and ongoing, regular shipments are scheduled.

Upon delivery to Pedanios, the product will be distributed to a network of more than 1,500 pharmacies across Germany, a country of more than 82 million people. Germany currently represents the largest single federally-legal medical cannabis market in the world, and is experiencing a significant shortage of supply. Through Pedanios, Aurora plans to become a top producer and supplier of medical cannabis products in Germany, as well as other European Union (EU) markets.

"This represents a huge milestone for Aurora and Pedanios, and a critical step in our aggressive international expansion strategy," said Neil Belot, Chief Global Business Development Officer. "Our team has done an outstanding job accelerating our entry into Europe. This is the first step in unlocking future potential markets in the EU of several hundred million people, and strongly validates Aurora's acquisition of Pedanios as one of the most significant strategic transactions to date in the cannabis industry."

Terry Booth, CEO, added, "With the receipt of our first international export/import permits and our first shipment to Germany complete, Aurora has further strengthened its position as one of the dominant operators in the global cannabis sector. Germany has more than twice Canada's population, with a rapidly-growing medical cannabis market that can currently be serviced by only four international producers – three of which have distributed product through Pedanios. Moreover, Pedanios provides a well-established gateway to the wider EU market, which continues to grow as additional countries proceed in improving patient access through the establishment of their own national medical cannabis systems. We will continue to diversify our operations, bring the Aurora Standard to new markets, and enjoy first mover advantages as we aim to set the cannabis industry standard across Europe and beyond."

About Aurora

Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations ("ACMPR"). The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, is currently constructing a second 800,000 square foot production facility, known as "Aurora Sky", at the Edmonton International Airport, and has acquired, and is undertaking completion of a third 40,000 square foot production facility in Pointe-Claire, Quebec, on Montreal's West Island.

In addition, the Company holds approximately 9.6% of the issued shares (12.9% on a fully-diluted basis) in leading extraction technology company Radient Technologies Inc., based in Edmonton, and is in the process of completing an investment in Edmonton-based Hempco Food and Fiber for an ownership stake of up to 50.1%. Furthermore, Aurora is the cornerstone investor with a 19.9% stake in Cann Group Limited, the first Australian company licensed to conduct research on and cultivate medical cannabis. Aurora also owns Pedanios, a leading wholesale importer, exporter, and distributor of medical cannabis in the European Union ("EU"), based in Germany. Aurora's common shares trade on TSX under the symbol "ACB".

On behalf of the Board of Directors,
AURORA CANNABIS INC.

Terry Booth
CEO

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Aurora Cannabis Inc.

For further information: Cam Battley, Executive Vice President, +1.905.864.5525, cam@auroramj.com, http://www.auroramj.com; Marc Lakmaaker, NATIONAL Equicom, mlakmaaker@national.ca, +1.416.848.1397
papapuff
 
Posts: 10921
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Tue Sep 19, 2017 10:32 am

570 News


MADD Canada applauds provincial Liberal plans for drug-impaired drivers

PROVINCIAL
by THE CANADIAN PRESS AND NEWS STAFF
Posted Sep 19, 2017


The province will have ‘zero tolerance’ for young or novice drug-impaired drivers, Ontario Premier Kathleen Wynne announced on Monday.

She made the announcement alongside Transportation Minister Steven Del Duca in Toronto, as the federal government moves ahead with marijuana legislation.

The penalties for drug-impaired driving will be in line with those for drunk drivers, Wynne said.

There will be zero tolerance for the following drivers:

young drivers aged 21 and under

novice drivers (G1, G2, M1, and M2 licence holders)

all commercial drivers


The federal government is working on a screening device, Queen’s Park said, and the province is moving to increase the fines for drivers who fail or refuse to perform a sobriety test.

The announcement comes a little over a week after Ontario’s Liberal government announced its plan to distribute and sell recreational cannabis in as many as 150 dedicated stores run by the province’s liquor control board and set the legal age to buy the drug at 19.

“We had a goal to balance the new freedom that people in Ontario will have to use cannabis recreationally with everyone’s expectation that it will be managed responsibly,” Wynne said.

Ontario Transportation Minister Steven Del Duca said the proposed changes would align both drug and alcohol impaired driving offences under the law in Ontario. The new legislation would also increase penalties for drivers who fail or refuse to provide a sample for a roadside test, he added.

“Let me be clear,” Del Duca said. “Driving while impaired is not acceptable and will not be tolerated. We believe that these measures are an important step towards ensuring that Ontario’s roads remain safe after July 1st, 2018.”

Under the proposed rules, young or novice drivers (with a G1, G2, M1 or M2 licence) would face licence suspensions from three to 30 days and fines from $250 to $450 if they have drugs or alcohol in their system. Currently, young and novice drivers face a 24-hour licence suspension and no monetary penalty.

Commercial drivers would face a three-day licence suspension and fines from $250 to $450 if they have drugs or alcohol in their system. Currently, there are no targeted suspension or monetary fines for commercial drivers under the province’s impaired driving laws.

Overall, under the proposed changes any driver who registers a warn or fail on a roadside screening device would be fined anywhere from $250 to $450. The current fine is $198. Drivers who refuse to provide a sample for a roadside test face a $550 fine under the proposed law, up from the current $198 fine.

The tougher Ontario penalties would be in addition to current federal criminal charges, suspensions and possible jail time for impaired driving. The federal government is expected to approve an oral fluid screening device for police to use to detect drug-impaired drivers in the coming months.

Mothers Against Drunk Driving Canada CEO Andrew Murie praised the province for its proposed laws and said he hopes other provinces follow Ontario’s example. The group has been calling for a zero tolerance approach to drivers who get behind the wheel with any drugs or alcohol in their system.

“We know that model of good legislation, education and enforcement works,” he said. “This is a big first step. It’s not going to be the last step.”

Progressive Conservative transportation critic Michael Harris said the new penalties don’t address the increased resources police will need to deal with drug-impaired driving.

“The Wynne Liberals have either underestimated, or are wilfully blind to how significant the needs of our police forces will be,” Harris said in a statement.

Last week, Officials from the Canadian Association of Chiefs of Police, Ontario Provincial Police and the Saskatoon Police Service told a federal committee they need more time to properly train officers about the new cannabis laws and more than double the number of police officers who are certified to conduct roadside drug-impaired driving testing.

If the government doesn’t postpone the start date there will be a window of six months to a year when police aren’t fully ready, which will allow organized crime to flourish, said OPP deputy commissioner for investigations and organized crime Rick Barnum.

Wynne said the province will host a fall summit with policing agencies, public health groups and other stakeholders to discuss Ontario’s marijuana legalization framework.

Wynne also appeared to leave the door open to expanding the sale of recreational marijuana if efforts to eliminate the black market are unsuccessful.

“If that means that ultimately we need more ways of making cannabis available in a safe and responsible way in order to tackle that illegal market then that’s something that we will look at,” she said.
papapuff
 
Posts: 10921
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Fri Sep 22, 2017 11:47 am

Delta-Optimist



East Ladner greenhouse to continue to use landfill gas

SANDOR GYARMATI / DELTA OPTIMIST

SEPTEMBER 22, 2017

A large-scale East Ladner greenhouse hoping to cash in on the medical and recreational marijuana markets will get heat and power from a greener form of energy.

Delta council has approved amending a restrictive covenant for Village Farms International, located in the 4500-block of 80th Street, to extend the operation of a landfill gas co-generation facility, which was to end later this month but will now be permitted until Sept. 30, 2027.

In 2002, part of the property was rezoned to allow for the operation of a landfill gas co-generation facility operated by Maxim Power Corp.

In 2013, a different portion of the property was rezoned to allow for the operation of a second, more advanced landfill gas co-generation facility operated by Quadrogen Power Systems Inc. That second facility is a demonstration project designed to convert gas from the Vancouver Landfill into multiple streams, including power, heat, hydrogen, CO2, bio-methane, bio-diesel and wax. That project was to have ended later this month, according to the terms of the restrictive covenant.

A report to council notes the extension is required because the facility is not complete and therefore has not been operational due to delays with meeting government funding approval requirements and establishing necessary agreements with government agencies.

“The applicant expects the facility to be operational in the next one or two years, allowing eight to nine years to run as a pilot project, test the technology and additional time for hardware retrofits for optimization of the process,” the report explains.

What the civic report does not mention is the greenhouse could see its crops shift from peppers and cucumbers to marijuana.

Village Farms International announced this summer it has entered into a $20-million joint venture with Emerald Health Therapeutics, a B.C.-based licensed producer of medical cannabis, to cultivate and distribute wholesale cannabis and cannabis extracts for medical purposes.

Also, if permitted by law, the operation plans to grow pot for “non-therapeutic” purposes.

Village Farms is initially allocating 25 acres for cannabis production. The joint venture also outlines an option to lease or purchase an additional 85 acres.

The initial 1.1 million square feet of greenhouse cannabis production is estimated to yield more than 75,000 kilograms of product annually. Village Farms notes the joint venture has the potential to have up to 4.8 million square feet of greenhouse production, estimated to yield more than 300,000 kilograms of product annually, which the company says would supply a considerable portion of the expected future cannabis demand in Canada or for export abroad.

Health Canada still has to approve the medical marijuana application, while the venture could also be an enormous one for recreational marijuana production if the federal government follows through with plans to legalize pot next summer.

Business in Vancouver named Village Farms one of 2017’s fastest growing companies in B.C.
papapuff
 
Posts: 10921
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Fri Sep 22, 2017 11:57 am

BarrieToday



Barrie entrepreneur goes from selling ice cream to cannabis concentrate

Keith Strachan on ground floor of $5M medical cannabis facility

by: Sue Sgambati

Keith Strachan has always had a keen eye for business.

At age 21, the Barrie entrepreneur and his brother owned a chip truck called Chips and Dips.

Next they opened Scoops and Cones, a popular ice cream hut at the waterfront.

"I've been an entrepreneur through and through. My brother and I own Scoops and Cones Ice Cream and we're part of the team at Kenzington Burger Bar. We definitely have the entrepreneurial spirit."

Strachan's day job was purchasing after he graduated from the program at Fanshaw College and he's worked with all levels of government.

He was doing freelance consulting writing government applications for cannabis producers when MediPharm Labs became his client for its application.

"I was drawn to their business model of just cannabis concentrates. I think there's a big niche there to be filled so I quickly became part of the team as one of the five founders," said Strachan, 32.

All the founders are from Simcoe County, along with the majority of the 20 shareholders. The company is seeking more investors.

Renovations are underway at a John Street building to install state of the art rooms similar to a pharmaceutical plant and tight security measures including a large vault to store the finished product and much more.

"Physical security measures as well as a lot of monitoring. There will be an onsite security guard, over 75 cameras and motion sensors throughout. Through the regulations, security is a huge concern," Strachan said.

The $5 million plant will process dry cannabis, not grow it.

The company will source the weed from various Canadian cultivators approved and licensed by Health Canada.

Through a series of steps, the dry cannabis is transformed into a liquid cannabis concentrate.

"Under our production now, we can process over 6,000 kilograms of dried cannabis on a monthly basis. As of right now that doesn't exist out there in the market. It's just not available yet so we'll grow as the industry grows," said Strachan.

The 23,000 square foot facility will employ about 15 people and is mostly automated with more skilled labour than large numbers.

The dried marijuana gets ground down and uses different 'recipes,' a 'super critical' CO2 vessel and a distillation process to make the cannabis concentrate.

"It comes out almost like a crude oil. It would be kind of black, not ready for consumption. So it goes through a distillation process to remove all the waxes and fats, get it down to a more pure oil and then we formulate it using a formation machine before it goes into a tincture bottle with a dropper or in a capsule," explains Strachan.

"With the tincture bottle, the patient can put a drop right under their tongue. It's a lot better for dosing. It's a little more accurate."

Strachan proudly points out that all the trades and building crews are local, keeping most of the renovation investment in Barrie.

He's also proud to be revitalizing an area with old, dated industrial buildings.

"We're the first to apply and receive a building permit for a medical cannabis facility in Barrie," he said. "We're taking a new industry and putting it in an old area which is a really good opportunity for Barrie."

MediPharm Labs is among probably about 400 other applicants awaiting licensing from Health Canada, mostly on the culitvation side but the company is getting its facility ready hoping the federal government prioritizes applications based on readiness.

Renovations will be done by Nov. 15.

The company is obviously interested in the recreation side of the industry but is focussing on the medical market for now and will see what new marijuana legislation brings.

And it will be very lucrative with initial projections of top line revenue at $25 million a year with profit yet to be determined.

"There's just a lot of opportunity. We have so much room to grow. With the automation and tehcnology we can produce concentrates as much demand. We don't foresee demand being a problem. We see ourselves as a solution to the demand."

For Barrie's first cannabis concentrate manufacturer, it's satisfying to see the faciility becoming a reality as he stands inside with work crews.

"It's kind of cool to see the walls being built after being in paperwork mode for so long."

But after eight years on the waterfront, there are no plans to sell Scoops and Cones.

"It's hard to give up the ice cream business. It's so fun."
papapuff
 
Posts: 10921
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Fri Sep 22, 2017 12:00 pm

Edmonton Journal


Opinion: Convenience stores a better option for pot retailing

Andrew Klukas ANDREW KLUKAS
Published on: September 22, 2017

In July 2018, the federal government will legalize the production and distribution of cannabis. Between now and then, the provinces and territories will have to decide how to adapt to this legislation.

Whether or not one agrees with legalization, everyone can agree that when it happens, the systems that the provinces put in place should promote the goals of legalization that, if realized, will be positive. Through its legislation, the federal government aims to move cannabis from the illegal market into a regulated system in which products can be taxed and where quality standards and controls protect citizens.

At least three things will be necessary to realize these goals. It’s already well-understood that if the prices of legal products are too high it will create an opportunity for illegal markets to persist. Secondly, legal products should come with readily identifiable, branded packaging. This will make them harder to counterfeit while providing the public with a guarantee of product standards of quality and safety.

The third necessity is a convenient distribution system for legal products. Think about it. If prohibition is ended for consumers, but the options to legally purchase products are too limited, this will create the conditions for a boom in the supply of illegal products through the underground market.

This is precisely what the province of Ontario is inviting through its recent proposal to limit supply to 150 government-owned sites by 2020. That distribution model will be vastly inadequate for Ontario and it will ensure that the illegal market thrives as the most convenient option for many consumers. Today, it’s easy to buy cannabis: If we make it hard to buy from legal sellers tomorrow, people will just continue to buy it elsewhere.

In other words, legalization can’t be successful if the provinces go only half-way. When consumption is legalized, the channels of distribution must allow sufficient access to the corresponding legal products. The new legal industry must be as inclusive as possible or underground activity will persist and, potentially, thrive.

To be clear, when we think of selling cannabis products in convenience stores we are thinking about the sale of pre-packaged, standardized products — not the sale of open products as seen in the many boutique “medical dispensaries” that have sprung up across the country.

Convenience stores are served by a distribution system that supports the legal sale of a variety of controlled goods, such as tobacco, and are well-positioned to adapt to include distribution of cannabis products as well. The stringent controls already in place to secure the collection of provincial and federal taxes on such products can accommodate any new products requiring similar controls — be they provincial or interprovincial.

Moreover, as found through a recent labour market study funded by the province of British Columbia, working in a convenience store, especially one with a gas station, requires a more complex set of skills and more responsibility than is commonly thought.

Employees are not simply cashiers or gas attendants. Their tasks are varied, complex and demand a high degree of accountability for compliance with government regulations regarding responsible retailing, health and safety, food and beverage preparation, and environmental protection. The framework for socially responsible retailing of cannabis is already well established.

Convenience stores are therefore well-prepared to handle the variety of quality-controlled products that will soon be entering the legal market. They successfully handle a variety of age-restricted products including alcohol in underserved or remote areas, and Health Canada studies confirms the strength of their commitment to age-testing.

They are perfectly capable of safely handling legal cannabis products subject to the regulations federal and provincial governments put in place to control their sale. And the existing producers of medicinal cannabis are already working to develop carefully branded recreational products containing consumer information to protect public safety.

The conditions for a successful legal market are in place. Those conditions include convenience stores. It’s up to provincial governments to ensure these conditions prevail.

Andrew Klukas is president of the Western Convenience Stores Association.
papapuff
 
Posts: 10921
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Fri Sep 22, 2017 12:33 pm

The Portugal News


Portugal set for €20m cannabis farm as doctors study benefits of medicinal weed

BY CARRIE-MARIE BRATLEY, IN NEWS · 21-09-2017

Canadian company Tilray, a world leader in the production of cannabis for medicinal purposes, has said it expects to invest €20 million in Portugal by 2020 to produce medicinal cannabis to supply the European market.

In comments to Lusa News Agency, the company said it chose Portugal because of the good weather for growing the plants. The country was also chosen because of its access to the common market and highly qualified biotechnology workers, Tilray said.

The fields, manufacturing units and laboratories in Cantanhede near Coimbra, will employ 100 people and the company expects to produce 60 tons a year by the end of 2018.

Medicinal cannabis and the derivatives produced in Portugal will be for the European market, particularly Germany, where the use of cannabis for therapeutic ends was legalised this year.

The medicinal use of cannabis is prohibited in Portugal, Lusa states, although some parties have said they want to legalise it for therapeutic and recreational purposes.

According to reports at the start of September, Portugal’s Doctors’ Association is currently studying the benefits of prescribing cannabis for therapeutic purposes, and its National Medicines Policies Committee will issue its views on the matter before the end of this year.

Speaking to newspaper i, Miguel Guimarães, Head of the Doctors’ Association, explained that the aim is “to analyse all evidence of clinical benefits and side effects, to understand under what circumstances the use could be positive.”

At stake is the prescription of marijuana to be smoked or ingested by patients, since no further legislative measures are necessary for cannabinoid medicines: once the medicines are authorised by [Portugal’s medicines watchdog] Infarmed, they can be prescribed by physicians for clinical use.

Prescription for marijuana for therapeutic purposes is now legal in 29 US states.

Since March, doctors in Germany have been authorised to prescribe cannabis in situations of chronic pain or during cancer treatment with chemotherapy, which up until now required special authorisation.

A consequence has been the scarcity of marijuana in pharmacies, since the country depends on imports.

The World Health Organisation recognises the therapeutic effects of cannabinoids in relieving nausea, particularly in advanced cancer, but believes that more studies are needed to understand how such drugs work, to seek better treatments.

Cannabis is the most widely-used drug in the European Union, with 23.5 million users in 2015.

It is estimated that 1 percent of European adults are daily consumers.

By 2015, 76,000 people began treatment due to problems with cannabis, an increase of almost 80 percent in a decade. In Portugal, the latest survey of the general population, conducted in 2012, indicated a 2.3 percent utilisation rate among the population, confirming that in Portugal, cannabis is also the most-consumed drug.

Meanwhile, the Left Bloc is also gunning to legalise the production, distribution and sale of cannabis for therapeutic and recreational purposes, and wants to use its new majority in parliament to achieve this.

To this end, the party, headed by Catarina Martins, was due to submit two bill proposals before summer, to broaden the decriminalisation of possession and consumption, which took place in 2001.

The PS socialist party has no official public stance on the matter, while the PCP Communists have said they are only open to discussing the matter for medicinal purposes.

Left Bloc MP, Moisés Ferreira, in comments to newspaper Público, said part of recent research “demonstrates the benefits of using cannabis in a number of diseases”, such as multiple sclerosis, glaucoma and eating disorders.

He explained that there is one cannabinoid-based drug authorised by Infarmed to be used in Portugal [Savitex], but it doesn’t exist on the market “not because it’s illegal but because doctors don’t prescribe it.”

As well as wanting cannabis-based drugs in pharmacies, the Left Bloc also wants patients who are prescribed cannabinoides to be able to purchase cannabis plants and grow them domestically.
papapuff
 
Posts: 10921
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

PreviousNext

Return to News

  • Advertisement
cron